Eradication of A fumigatus is inhibited by ibrutinib. Effective clearance of Aspergillus requires macrophage activation and subsequent neutrophil recruitment. This activation is a Btk-dependent process, and inhibitors of Btk, such as ibrutinib, preclude effective clearance of A fumigatus, predisposing patients to invasive infection.